Of Consents And Consorts: Reporting Ethics, Law, And Human Rights In Rcts Involving Monitored Overdose Of Healthy Volunteers Pre And Post The “Consort” Guidelines

References

• Meulenbelt J, Mensingam TT, Kortboyer JM, Speijers GJ, de Vries I. Healthy volunteer studies in toxicology. Toxicol Lett 1998; 102–103: 35–39
   PubMed Web of Science ®Google Scholar
• McBride G. Phase one trials can exploit terminally ill patients. Br Med J 1994; 308(6930)679–680
   PubMed Web of Science ®Google Scholar
• Steinbrook R. Improving protection for research subjects. N Engl J Med 2002; 346(18)1425–1430
   PubMed Web of Science ®Google Scholar
• Day RO, Chalmers DR, Williams KM, Campbell TJ. The death of a healthy volunteer in a human research project: implications for Australian clinical research. Med J Aust 1998; 168(9)449–451
   PubMed Web of Science ®Google Scholar
• Shalala D. Protecting research subjects—what must be done. N Engl J Med 2000; 343(11)808–810
   PubMed Web of Science ®Google Scholar
• , CIOMS. International Ethical Guidelines for Biomedical Research Involving Human Subjects. 2002.
   Google Scholar
• Boyd R. A view from the man in the seat opposite. Br Med J 1998; 317(7155)410
   PubMed Web of Science ®Google Scholar
• Lumley CE, Parkinson C, Walker SR. An international appraisal of the minimum duration of chronic animal toxicity studies. Hum Exp Toxicol 1992; 11(3)155–162
   PubMed Web of Science ®Google Scholar
• Ryffel B. Unanticipated human toxicology of recombinant proteins. Arch. Toxicol. Suppl 1996; 18: 333–341
   PubMedGoogle Scholar
• Wager E, Tooley PJ, Emanuel MB, Wood SF. How to do it. Get patients' consent to enter clinical trials. Br Med J 1995; 311(7007)734–737
   Google Scholar
• Kalb PE, Koehler KG. Legal issues in scientific research. J Am Med Assoc 2002; 287(1)85–91
   Web of Science ®Google Scholar
• Ruiz-Canela M, Martinez-Gonzalez MA, Gomez-Gracia E, Fernandez-Crehuet J. Informed consent and approval by institutional review boards in published reports on clinical trials. N Engl J Med 1999; 340(14)1114–1115
   PubMed Web of Science ®Google Scholar
• Bromhead HJ, Goodman NW. CONSORT statement on the reporting standards of clinical trials. Reporting of refusal of consent to take part in clinical trials is still poor. Br Med J 1997; 314(7087)1126–1127
   PubMed Web of Science ®Google Scholar
• Begg C, Cho M, Eastwood S, Horton R, Moher D, Olkin I, Pitkin R, Rennie D, Schulz KF, Simel D, Stroup DF. Improving the quality of reporting of randomized controlled trials. The CONSORT statement. J Am Med Assoc 1996; 276(8)637–639
   PubMed Web of Science ®Google Scholar
• Call for comments on a proposal to improve reporting of clinical trials in the biomedical literature. Working Group on Recommendations for Reporting of Clinical Trials in the Biomedical Literature. Ann Intern Med 1994; 121(11)894–895
   PubMed Web of Science ®Google Scholar
• A proposal for structured reporting of randomized controlled trials. The Standards of Reporting Trials Group. J Am Med Assoc 1994; 272(24)1926–1931
   PubMed Web of Science ®Google Scholar
• Altman DG, Schulz KF, Moher D, Egger M, Davidoff F, Elbourne D, Gøtzsche PC, Lang T. The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med 2001; 134(8)663–694
   PubMed Web of Science ®Google Scholar
• Davidoff F. News from the International Committee of Medical Journal Editors. Ann Intern. Med 2000; 133(3)229–231
   PubMed Web of Science ®Google Scholar
• Moher D, Jones A, Lepage L. Use of the CONSORT statement and quality of reports of randomized trials: A comparative before-and-after evaluation. J Am Med Assoc 2001; 285(15)1992–1995
   PubMed Web of Science ®Google Scholar
• , International Conference on Harmonisation Good Clinical Practice (ICHGCP). Guidelines for Good Clinical Practice. In: Foster C, ed. Manual for Research Ethics Committees. 5th ed. London: Kings College; 1997, p. 1–30.
   Google Scholar
• McNamara RM, Aaron CK, Gemborys M, Davidheiser S. Efficacy of charcoal cathartic versus ipecac in reducing serum acetaminophen in a simulated overdose. Ann Emerg Med 1989; 18(9)934–938
   PubMed Web of Science ®Google Scholar
• Eisen TF, Grbcich PA, Lacouture PG, Shannon MW, Woolf A. The adsorption of salicylates by a milk chocolate–charcoal mixture. Ann Emerg Med 1991; 20(2)143–146
   PubMed Web of Science ®Google Scholar
• Keller RE, Schwab RA, Krenzelok EP. Contribution of sorbitol combined with activated charcoal in prevention of salicylate absorption. Ann Emerg Med 1990; 19(6)654–656
   PubMed Web of Science ®Google Scholar
• Dillon EC, Jr, Wilton JH, Barlow JC, Watson WA. Large surface area activated charcoal and the inhibition of aspirin absorption. Ann Emerg Med 1989; 18(5)547–552
   PubMed Web of Science ®Google Scholar
• Remmert HP, Olling M, Slob W, van der Giesen WF, van Dijk A, et al. Comparative antidotal efficacy of activated charcoal tablets, capsules and suspension in healthy volunteers. Eur J Clin Pharmacol 1990; 39(5)501–505
   PubMed Web of Science ®Google Scholar
• Rose SR, Gorman RL, Oderda GM, Klein-Schwartz W, Watson WA. Simulated acetaminophen overdose: pharmacokinetics and effectiveness of activated charcoal. Ann Emerg Med 1991; 20(10)1064–1068
   PubMed Web of Science ®Google Scholar
• Kirshenbaum LA, Mathews SC, Sitar DS, Tenenbein M. Whole-bowel irrigation versus activated charcoal in sorbitol for the ingestion of modified-release pharmaceuticals. Clin Pharmacol Ther 1989; 46(3)264–271
   PubMed Web of Science ®Google Scholar
• Yeates PJ, Thomas SH. Effectiveness of delayed activated charcoal administration in simulated paracetamol (acetaminophen) overdose. Br J Clin Pharmacol 2000; 49(1)11–14
   PubMed Web of Science ®Google Scholar
• Lapatto-Reiniluoto O, Kivisto KT, Neuvonen PJ. Effect of activated charcoal alone or given after gastric lavage in reducing the absorption of diazepam, ibuprofen and citalopram. Br J Clin Pharmacol 1999; 48(2)148–153
   PubMed Web of Science ®Google Scholar
• Green R, Grierson R, Sitar DS, Tenenbein M. How long after drug ingestion is activated charcoal still effective?. J Toxicol Clin Toxicol 2001; 39(6)601–605
   PubMed Web of Science ®Google Scholar
• Rangan C, Nordt SP, Hamilton R, Ingels M, Clark RF. Treatment of acetaminophen ingestion with a superactivated charcoal–cola mixture. Ann Emerg Med 2001; 37(1)55–58
   PubMed Web of Science ®Google Scholar
• Elomaa K, Ranta S, Tuominen J, Lahteenmaki P. Charcoal treatment and risk of escape ovulation in oral contraceptive users. Hum Reprod 2001; 16(1)76–81
   PubMed Web of Science ®Google Scholar
• Orisakwe OE, Ilondu ND, Afonne OJ, Ofoefule SI, Orish CN, Agbasi PU. Effect of activated charcoal on diethylcarbamazine absorption in humans. Am J Ther 2001; 8(1)7–9
   PubMedGoogle Scholar
• Savulescu J. Commentary: safety of participants in non-therapeutic research must be ensured. Br Med J 1998; 316(7135)891–892
   PubMed Web of Science ®Google Scholar
• Skene L, Smallwood R. Informed consent: lessons from Australia. Br Med J 2002; 324(7328)39–41
   PubMed Web of Science ®Google Scholar
• Yank V, Rennie D. Reporting of informed consent and ethics committee approval in clinical trials. J Am Med Assoc 2002; 287(21)2835–2838
   PubMed Web of Science ®Google Scholar
• Steinbrook R. Protecting research subjects—the crisis at Johns Hopkins. N Engl J Med 2002; 346(9)716–720
   PubMed Web of Science ®Google Scholar
• Christian MC, Goldberg JL, Killen J, Abrams JS, McCabe MS, Mauer JK, et al. A central institutional review board for multi-institutional trials. N Engl J Med 2002; 346(18)1405–1408
   PubMed Web of Science ®Google Scholar
• Miller FG, Rosenstein DL. Reporting of ethical issues in publications of medical research. Lancet 2002; 360: 1326–1328
   PubMed Web of Science ®Google Scholar